JP2016539959A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016539959A5 JP2016539959A5 JP2016537431A JP2016537431A JP2016539959A5 JP 2016539959 A5 JP2016539959 A5 JP 2016539959A5 JP 2016537431 A JP2016537431 A JP 2016537431A JP 2016537431 A JP2016537431 A JP 2016537431A JP 2016539959 A5 JP2016539959 A5 JP 2016539959A5
- Authority
- JP
- Japan
- Prior art keywords
- aqueous component
- use according
- implantitis
- peri
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000006389 Peri-Implantitis Diseases 0.000 claims 12
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 6
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 6
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 6
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 6
- 239000004472 Lysine Substances 0.000 claims 6
- 235000001014 amino acid Nutrition 0.000 claims 6
- 229940024606 amino acid Drugs 0.000 claims 6
- 150000001413 amino acids Chemical class 0.000 claims 6
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- 238000009472 formulation Methods 0.000 claims 6
- 235000013922 glutamic acid Nutrition 0.000 claims 6
- 239000004220 glutamic acid Substances 0.000 claims 6
- 235000005772 leucine Nutrition 0.000 claims 6
- 235000018977 lysine Nutrition 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 6
- 230000002265 prevention Effects 0.000 claims 6
- 230000001225 therapeutic effect Effects 0.000 claims 6
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 4
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical compound [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 claims 4
- 239000002202 Polyethylene glycol Substances 0.000 claims 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 4
- 150000001805 chlorine compounds Chemical class 0.000 claims 4
- 229910001919 chlorite Inorganic materials 0.000 claims 4
- 229910052619 chlorite group Inorganic materials 0.000 claims 4
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 claims 4
- 239000000463 material Substances 0.000 claims 4
- 229920001223 polyethylene glycol Polymers 0.000 claims 4
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims 4
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims 4
- 239000000126 substance Substances 0.000 claims 4
- 239000004475 Arginine Substances 0.000 claims 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 2
- 239000005708 Sodium hypochlorite Substances 0.000 claims 2
- 229910010413 TiO 2 Inorganic materials 0.000 claims 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 2
- 235000004279 alanine Nutrition 0.000 claims 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 2
- 235000009697 arginine Nutrition 0.000 claims 2
- 235000009582 asparagine Nutrition 0.000 claims 2
- 229960001230 asparagine Drugs 0.000 claims 2
- 235000003704 aspartic acid Nutrition 0.000 claims 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 2
- 125000003636 chemical group Chemical group 0.000 claims 2
- 239000000460 chlorine Substances 0.000 claims 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 2
- 235000004554 glutamine Nutrition 0.000 claims 2
- 150000004676 glycans Chemical class 0.000 claims 2
- -1 hydrazine derivative compounds Chemical class 0.000 claims 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical class ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims 2
- 229960000310 isoleucine Drugs 0.000 claims 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 2
- 235000014705 isoleucine Nutrition 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 claims 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims 2
- 229920001282 polysaccharide Polymers 0.000 claims 2
- 239000005017 polysaccharide Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims 2
- 208000003265 stomatitis Diseases 0.000 claims 2
- 238000001356 surgical procedure Methods 0.000 claims 2
- 239000004474 valine Substances 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1351468 | 2013-12-09 | ||
| SE1351468-2 | 2013-12-09 | ||
| SE1450452-6 | 2014-04-11 | ||
| SE1450452 | 2014-04-11 | ||
| PCT/EP2014/076909 WO2015086535A1 (en) | 2013-12-09 | 2014-12-08 | Preparation for prevention and/or treatment of peri-implantitis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016539959A JP2016539959A (ja) | 2016-12-22 |
| JP2016539959A5 true JP2016539959A5 (https=) | 2018-01-18 |
| JP6458035B2 JP6458035B2 (ja) | 2019-01-23 |
Family
ID=52014107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016537431A Active JP6458035B2 (ja) | 2013-12-09 | 2014-12-08 | インプラント周囲炎の予防および／または治療のための製剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20160310525A1 (https=) |
| EP (1) | EP3079657B8 (https=) |
| JP (1) | JP6458035B2 (https=) |
| WO (1) | WO2015086535A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12558335B2 (en) * | 2019-09-19 | 2026-02-24 | Rls Global Ab | Preparation for removal and/or prevention of an infection associated with Staphylococcus epidermidis |
| RU2760169C1 (ru) * | 2021-02-05 | 2021-11-22 | Федеральное государственное бюджетное военное образовательное учреждение высшего образования "Военно-медицинская академия имени С.М. Кирова" Министерства обороны Российской Федерации (ВМедА) | Способ профилактики осложнений после установки дентальных имплантатов |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE507437C2 (sv) * | 1996-11-14 | 1998-06-08 | Medi Team Dentalutveckling I G | Preparat för användning vid kemisk-mekanisk behandling av kariesangrepp och förfarande för framställning av preparatet |
| NL2004260C2 (en) * | 2010-02-18 | 2011-08-22 | Univ Amsterdam | Disinfectant composition and its use in dental treatment. |
| JP5952899B2 (ja) * | 2011-06-15 | 2016-07-13 | アルエルエス グローバル アーベー | う蝕象牙質組織の検出と除去 |
-
2014
- 2014-12-08 EP EP14809015.2A patent/EP3079657B8/en active Active
- 2014-12-08 US US15/102,168 patent/US20160310525A1/en not_active Abandoned
- 2014-12-08 JP JP2016537431A patent/JP6458035B2/ja active Active
- 2014-12-08 WO PCT/EP2014/076909 patent/WO2015086535A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015522632A5 (https=) | ||
| JP2007153910A5 (https=) | ||
| JP2012107014A5 (https=) | ||
| ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
| RU2019107791A (ru) | Многофазная композиция для перорального применения для доставки активных веществ для ухода за ротовой полостью | |
| JP2018021007A5 (https=) | ||
| WO2015082937A3 (en) | Composition comprising hydrochlorous acid and uses thereof | |
| JP2004504333A5 (https=) | ||
| CN108026053A8 (zh) | 作为mIDH1抑制剂的稠合的咪唑类化合物 | |
| JP2009531457A5 (https=) | ||
| TR200806298A2 (tr) | Farmasötik formülasyon | |
| CY1108684T1 (el) | Φαρμακευτικες συνθεσεις που περιλαμβανουν ασκορβικο οξυ για τη θεραπεια μυκητοειδων υπερμολυνσεων και μυκητοειδων επανεμφανισεων | |
| WO2005118166A3 (en) | Pharmaceutical composition containing irbesartan | |
| JP2017002035A5 (https=) | ||
| AR111550A1 (es) | Formulaciones de ácido 1-amino-1-ciclopropanocarboxílico | |
| JP2016503058A5 (https=) | ||
| JP2017514924A5 (https=) | ||
| WO2015171460A3 (en) | Formulations of cyclophosphamide liquid concentrate | |
| WO2018234871A3 (en) | COMPOSITIONS FOR DRUG DELIVERY AND METHODS OF USE | |
| MX2021001145A (es) | Formulación de liberación inmediata de una combinación triple de principios activos farmacéuticos, útil en el tratamiento del síndrome del ovario poliquístico. | |
| JP2016535044A5 (https=) | ||
| JP2016539959A5 (https=) | ||
| JP2015500252A5 (https=) | ||
| JP2015157874A5 (https=) | ||
| AU2018263059A1 (en) | Compositions and treatment procedures for the treatment of pathogenic infections |